咀嚼混合能力测试在头颈部癌症患者和健康对照者中的咀嚼效能评估的可靠性研究。
Reliability of the mixing ability test testing masticatory performance in patients with head and neck cancer and healthy controls.
机构信息
Imaging Division, Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Department of Oral and Maxillofacial Surgery and Special Dental Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
出版信息
J Oral Rehabil. 2020 Aug;47(8):961-966. doi: 10.1111/joor.13029. Epub 2020 Jun 20.
BACKGROUND
Treatment of patients with head and neck cancer can result in disrupted mastication. To measure masticatory performance in people with compromised mastication, the mixing ability test (MAT) was developed.
OBJECTIVE
In this study, the reliability of the MAT was evaluated in patients with head and neck cancer and healthy controls.
METHODS
Thirty-four patients with head and neck cancer and 42 healthy controls performed the MAT twice on the same day. To assess reliability, the intra-class correlation coefficient (ICC ), standard error of measurement (SEM), smallest detectable change (SDC) and limits of agreement (LoA) were calculated.
RESULTS
A good (ICC = 0.886) and moderate correlation (ICC = 0.525) were found for patients and healthy controls, respectively. Patients had a worse mixing ability (mean = 19.12, SD = 4.56) in comparison with healthy controls (mean = 16.42, SD = 2.04). The SEM was 0.76 in patients and 1.45 in healthy controls, with a SDC of 2.12 and 4.02, respectively. The LoA was -4.46 to 4.42 in patients and -3.65 to 4.59 in healthy controls.
CONCLUSION
The MAT has a good reliability in patients with head and neck cancer and a moderate reliability in healthy controls.
背景
头颈部癌症患者的治疗可能导致咀嚼功能紊乱。为了衡量咀嚼功能受损患者的咀嚼能力，开发了混合能力测试（MAT）。
目的
本研究旨在评估 MAT 在头颈部癌症患者和健康对照组中的可靠性。
方法
34 例头颈部癌症患者和 42 例健康对照者在同一天内进行了两次 MAT。为了评估可靠性，计算了组内相关系数（ICC）、测量标准差（SEM）、最小可检测变化（SDC）和一致性界限（LoA）。
结果
患者和健康对照组的 ICC 值分别为 0.886（良好）和 0.525（中度）。与健康对照组（均值=16.42，标准差=2.04）相比，患者的混合能力更差（均值=19.12，标准差=4.56）。患者的 SEM 为 0.76，健康对照组为 1.45，SDC 分别为 2.12 和 4.02。患者的 LoA 为-4.46 至 4.42，健康对照组为-3.65 至 4.59。
结论
MAT 在头颈部癌症患者中具有良好的可靠性，在健康对照组中具有中度可靠性。
Zotero 插件